Argyle Capital Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $9.9M | Sell |
10,767
-310
| -3% | -$314K | 3.22% | 2 |
|
|
2025
Q4 | $11.9M | Sell |
11,077
-30
| -0.3% | -$28.7K | 3.97% | 2 |
|
|
2025
Q3 | $8.47M | Sell |
11,107
-20
| -0.2% | -$14.9K | 2.93% | 3 |
|
|
2025
Q2 | $8.67M | Sell |
11,127
-390
| -3% | -$303K | 3.14% | 2 |
|
|
2025
Q1 | $9.51M | Sell |
11,517
-10
| -0.1% | -$8.32K | 3.53% | 2 |
|
|
2024
Q4 | $8.9M | Hold |
11,527
| – | – | 3.51% | 2 |
|
|
2024
Q3 | $10.2M | Sell |
11,527
-1,101
| -9% | -$990K | 4.07% | 2 |
|
|
2024
Q2 | $11.4M | Sell |
12,628
-1,405
| -10% | -$1.12M | 4.7% | 2 |
|
|
2024
Q1 | $10.9M | Sell |
14,033
-4,434
| -24% | -$3.16M | 4.22% | 2 |
|
|
2023
Q4 | $10.8M | Sell |
18,467
-3,715
| -17% | -$2.17M | 4.46% | 2 |
|
|
2023
Q3 | $11.9M | Sell |
22,182
-724
| -3% | -$373K | 4.36% | 2 |
|
|
2023
Q2 | $10.7M | Sell |
22,906
-1,162
| -5% | -$487K | 3.87% | 2 |
|
|
2023
Q1 | $8.27M | Sell |
24,068
-995
| -4% | -$336K | 2.91% | 2 |
|
|
2022
Q4 | $9.17M | Sell |
25,063
-409
| -2% | -$145K | 3.15% | 2 |
|
|
2022
Q3 | $8.24M | Sell |
25,472
-876
| -3% | -$278K | 3.21% | 2 |
|
|
2022
Q2 | $8.54M | Sell |
26,348
-150
| -0.6% | -$45K | 3.06% | 2 |
|
|
2022
Q1 | $7.59M | Sell |
26,498
-1,075
| -4% | -$277K | 2.47% | 2 |
|
|
2021
Q4 | $7.62M | Sell |
27,573
-566
| -2% | -$143K | 2.38% | 3 |
|
|
2021
Q3 | $6.5M | Sell |
28,139
-200
| -0.7% | -$49.4K | 2.15% | 5 |
|
|
2021
Q2 | $6.5M | Sell |
28,339
-340
| -1% | -$68.3K | 2.1% | 7 |
|
|
2021
Q1 | $5.36M | Sell |
28,679
-1,030
| -3% | -$201K | 1.81% | 11 |
|
|
2020
Q4 | $5.02M | Sell |
29,709
-1,165
| -4% | -$174K | 1.87% | 14 |
|
|
2020
Q3 | $4.57M | Sell |
30,874
-300
| -1% | -$46.4K | 1.87% | 12 |
|
|
2020
Q2 | $5.12M | Sell |
31,174
-5,458
| -15% | -$838K | 2.15% | 5 |
|
|
2020
Q1 | $5.08M | Sell |
36,632
-100
| -0.3% | -$13.7K | 2.4% | 5 |
|
|
2019
Q4 | $4.83M | Sell |
36,732
-500
| -1% | -$58K | 1.71% | 16 |
|
|
2019
Q3 | $4.16M | Sell |
37,232
-300
| -0.8% | -$33.4K | 1.57% | 18 |
|
|
2019
Q2 | $4.16M | Hold |
37,532
| – | – | 1.58% | 18 |
|
|
2019
Q1 | $4.87M | Sell |
37,532
-90
| -0.2% | -$10.9K | 1.87% | 12 |
|
|
2018
Q4 | $4.35M | Sell |
37,622
-750
| -2% | -$83.8K | 1.84% | 12 |
|
|
2018
Q3 | $4.12M | Sell |
38,372
-60
| -0.2% | -$6K | 1.54% | 20 |
|
|
2018
Q2 | $3.28M | Sell |
38,432
-100
| -0.3% | -$8.21K | 1.3% | 34 |
|
|
2018
Q1 | $2.98M | Sell |
38,532
-1,400
| -4% | -$113K | 1.18% | 36 |
|
|
2017
Q4 | $3.37M | Hold |
39,932
| – | – | 1.26% | 33 |
|
|
2017
Q3 | $3.42M | Hold |
39,932
| – | – | 1.34% | 33 |
|
|
2017
Q2 | $3.29M | Hold |
39,932
| – | – | 1.33% | 34 |
|
|
2017
Q1 | $3.36M | Hold |
39,932
| – | – | 1.37% | 30 |
|
|
2016
Q4 | $2.94M | Sell |
39,932
-1,517
| -4% | -$113K | 1.25% | 32 |
|
|
2016
Q3 | $3.33M | Sell |
41,449
-700
| -2% | -$56K | 1.44% | 24 |
|
|
2016
Q2 | $3.32M | Hold |
42,149
| – | – | 1.41% | 25 |
|
|
2016
Q1 | $3.04M | Sell |
42,149
-450
| -1% | -$34K | 1.38% | 25 |
|
|
2015
Q4 | $3.59M | Sell |
42,599
-300
| -0.7% | -$24.9K | 1.65% | 17 |
|
|
2015
Q3 | $3.59M | Sell |
42,899
-12,850
| -23% | -$1.08M | 1.75% | 19 |
|
|
2015
Q2 | $4.65M | Hold |
55,749
| – | – | 2.13% | 6 |
|
|
2015
Q1 | $4.05M | Hold |
55,749
| – | – | 1.81% | 14 |
|
|
2014
Q4 | $3.85M | Hold |
55,749
| – | – | 1.69% | 21 |
|
|
2014
Q3 | $3.62M | Hold |
55,749
| – | – | 1.67% | 23 |
|
|
2014
Q2 | $3.47M | Hold |
55,749
| – | – | 1.62% | 25 |
|
|
2014
Q1 | $3.28M | Sell |
55,749
-1,000
| -2% | -$55.8K | 1.61% | 25 |
|
|
2013
Q4 | $2.89M | Buy |
56,749
+850
| +2% | +$42.6K | 1.46% | 28 |
|
|
2013
Q3 | $2.81M | Hold |
55,899
| – | – | 1.54% | 27 |
|
|
2013
Q2 | $2.75M | Buy |
+55,899
| New | +$3.04M | 1.57% | 26 |
|
Other funds holding LLY
VCM
VPM
Argyle Capital Management's LLY Position: Q1 2026 in Review
Argyle Capital Management reduced its Eli Lilly (LLY) stake by 2.8% in Q1 2026, selling an estimated $314K and leaving 10,767 shares worth $9.9M. The position accounts for 3.22% of the portfolio, ranked #2.
Argyle Capital Management first reported a position in LLY in Q2 2013 and has held it in 52 quarters since. The position peaked at $11.9M in Q3 2023. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- Argyle Capital Management held 10,767 shares of Eli Lilly worth $9.9M as of Q1 2026.
- Argyle Capital Management sold 310 Eli Lilly shares in Q1 2026, an estimated $314K.
- Eli Lilly made up 3.22% of Argyle Capital Management's portfolio in Q1 2026, its #2 holding.
- Argyle Capital Management first reported a position in Eli Lilly in Q2 2013 and has held it in 52 quarters since.
- Argyle Capital Management's Eli Lilly position peaked at $11.9M in Q3 2023.
- 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on Argyle Capital Management's 13F filing for Q1 2026, filed 28 Apr 2026.